Figures & data
Figure 2 Increased acute wound closure rate seen with AFS over SIS in an acute wound care model.
Abbreviations: AFS, acellular fish skin; SIS, small intestine submucosa.
![Figure 2 Increased acute wound closure rate seen with AFS over SIS in an acute wound care model.](/cms/asset/5c27d2cd-590f-4ec6-99de-dbdf00289ee8/dcwc_a_12191471_f0002_b.jpg)
Figure 3 Increased acute wound closure rate seen with AFS over dHACM in an acute wound care model.
Abbreviations: AFS, acellular fish skin; dHACM, dehydrated human amnion/chorion membrane.
![Figure 3 Increased acute wound closure rate seen with AFS over dHACM in an acute wound care model.](/cms/asset/546c04b6-918a-46a8-92a2-52073824e7c9/dcwc_a_12191471_f0003_b.jpg)
Figure 4 Efficacy of AFS as a bacterial barrier and the increased efficacy seen with the addition of greater omega-3 fatty acids.
Abbreviation: AFS, acellular fish skin.
![Figure 4 Efficacy of AFS as a bacterial barrier and the increased efficacy seen with the addition of greater omega-3 fatty acids.](/cms/asset/9fc26777-1d06-42b5-9a87-89c042cdfd28/dcwc_a_12191471_f0004_b.jpg)
Figure 5 Clinical use of antibiotics before and after the application of AFS in a cohort of chronic wound patients.
Abbreviation: AFS, acellular fish skin.
![Figure 5 Clinical use of antibiotics before and after the application of AFS in a cohort of chronic wound patients.](/cms/asset/6e18d520-5d4f-40d6-a154-e57d60fff8cc/dcwc_a_12191471_f0005_b.jpg)
Table 1 Studies evaluating the use of AFS in wound healing
Figure 6 Mean wound surface area as noted during the 5-week AFS treatment and 3-week follow-up of venous leg ulcers.Citation11
Abbreviation: AFS, acellular fish skin.
![Figure 6 Mean wound surface area as noted during the 5-week AFS treatment and 3-week follow-up of venous leg ulcers.Citation11](/cms/asset/b4584e0a-7fe4-4406-92df-792236faa3ff/dcwc_a_12191471_f0006_b.jpg)
Table 2 Likelihood of healing by prognostic factors
Figure 7 (A) Post-debrided foot with exposed bone. (B) Completion of transmetatarsal amputation. (C) Placement of AFS. (D) Post-op day 4 with no negative-pressure wound therapy. (E) Three weeks after grafting.
![Figure 7 (A) Post-debrided foot with exposed bone. (B) Completion of transmetatarsal amputation. (C) Placement of AFS. (D) Post-op day 4 with no negative-pressure wound therapy. (E) Three weeks after grafting.](/cms/asset/46657b6a-c88e-43ef-bdd9-d4dedc5582a0/dcwc_a_12191471_f0007_c.jpg)
Figure 8 Levels of omega-3 and omega-6 fatty acids in various products with y-axis being the percent of fatty acid and x-axis being the type of fatty acid.
![Figure 8 Levels of omega-3 and omega-6 fatty acids in various products with y-axis being the percent of fatty acid and x-axis being the type of fatty acid.](/cms/asset/083a2cbc-1d31-4e83-a05f-1b9950bd61e3/dcwc_a_12191471_f0008_c.jpg)
Table 3 Porcine burn model treatment groups
Figure 9 Progression of porcine wound closure when treated with AFS with and without skin grafting.
![Figure 9 Progression of porcine wound closure when treated with AFS with and without skin grafting.](/cms/asset/bdef84f4-4f1b-4a3f-bd40-cc27980d1a55/dcwc_a_12191471_f0009_c.jpg)